聚氧乙烯聚氧丙烯嵌段共聚物(聚醚F-68) Polyoxyethylene Polyoxypropylene Glycol (160E.O.) (30P.O.)

聚氧乙烯聚氧丙烯嵌段共聚物(聚醚F-68)
Polyoxyethylene Polyoxypropylene Glycol (160E.O.) (30P.O.)

  • 产品特性
  • 相关资料
  • Q&A
  • 参考文献

聚氧乙烯聚氧丙烯嵌段共聚物(聚醚F-68)聚氧乙烯聚氧丙烯嵌段共聚物(聚醚F-68)                              Polyoxyethylene Polyoxypropylene Glycol (160E.O.) (30P.O.)

Polyoxyethylene Polyoxypropylene Glycol (160E.O.) (30P.O.)


生产商:FUJIFILM Wako Pure Chemical Corporation
保存条件 : 冷藏(冷藏运输)
CAS RN® : 9003-11-6

分子式:HO(C2H4O)x.(C3H6O)y.(C2H4O)zH

产品别名:普朗尼克F-68、聚醚 F-68、泊洛沙姆188

◆产品概况 · 用途


普朗尼克型非离子表面活性剂,毒性相对较低。

· 在细胞培养中,添加到培养基中可防止细胞粘附到培养瓶上,并可抑制细胞聚集

· 作为消泡剂使用时,可防止培养基起泡,并减少由于通气、搅拌等引起的剪切应力,起到保护细胞的作用

· 由于毒性低,对皮肤刺激小,可用作化妆品的增溶剂、乳化剂和清洗剂

 


◆细胞培养级CultureSure™ 10w/v%聚氧乙烯聚氧丙烯嵌段共聚物


■ 特点


● 内毒素含量 ≤ 0.5EU/mL

● 经无菌测试

● 经支原体检测

 


■ 物性信息


外观:无色透明液体

浓度:9.7 ~ 10.3w/v%

纯度:内毒素含量 ≤ 0.5EU/mL

 产品列表


产品编号

产品名称

规格

包装

033-23391

CultureSure 10w/v% Polyoxyethylene

 Polyoxypropylen CultureSure™ 10w/v% 聚氧乙烯聚氧丙烯嵌段共聚物

for Cell Culture

100 mL

◆生化级聚醚聚氧乙烯聚氧丙烯嵌段共聚物


■ 特点


● 乳化、增溶、分散力强

● 吸湿性低于烷基芳基磺酸盐

● 毒性低

 


■ 物性信息


外观:白色~浅黄色,片状

溶解性:溶于水和乙醇

■ 产品列表

产品编号

产品名称

规格

包装

160-25231

Polyoxyethylene Polyoxypropylene Glycol (160E.O.)   (30P.O.)

聚氧乙烯聚氧丙烯嵌段共聚物(160E.O.) (30P.O.)

for Biochemistry

100 g

162-25235

500 g

※ 本页面产品仅供研究用,研究以外不可使用。

CultureSure(R) 10w/v% Polyoxyethylene Polyoxypropylene Glycol Solution CultureSure® 10w/v%聚氧乙烯聚氧丙烯嵌段共聚物 品牌:FUJIFILM Wako


CultureSure(R) 10w/v% Polyoxyethylene Polyoxypropylene Glycol Solution

CultureSure® 10w/v%聚氧乙烯聚氧丙烯嵌段共聚物

品牌:FUJIFILM Wako
CAS No.:2594628
储存条件:室温
纯度:
产品编号

(生产商编号)

等级 规格 运输包装 零售价(RMB) 库存情况 参考值

033-23391

for Cell Culture 100mL 咨询


* 干冰运输、大包装及大批量的产品需酌情添加运输费用


* 零售价、促销产品折扣、运输费用、库存情况、产品及包装规格可能因各种原因有所变动,恕不另行通知,确切详情请联系上海金畔生物科技有限公司。

Cremophor EL(Synonyms: 聚氧乙烯蓖麻油EL)

生化分析试剂 Biochemical Assay Reagents
Cremophor EL;(Synonyms: 聚氧乙烯蓖麻油EL)

Cremophor EL 是一种聚氧乙烯蓖麻油衍生物,是一种非离子表面活性剂。Cremophor EL 被广泛用于改善药物的溶解和输送。

Cremophor EL(Synonyms: 聚氧乙烯蓖麻油EL)

Cremophor EL Chemical Structure

CAS No. : 61791-12-6

规格 价格 是否有货 数量
100 mL ¥800 In-stock
200 mL ; 询价 ;
500 mL ; 询价 ;

* Please select Quantity before adding items.

生物活性

Cremophor EL, a polyoxyethylene castor oil derivative, is a nonionic surfactant. Cremophor EL is widely employed to improve dissolution and delivery of drugs[1].

体外研究
(In Vitro)

Cremophor EL is a widely used excipient. In the first 10 h, Cremophor EL at 5 mg/mL increases the impedance, then decreases it, and after 20 h of treatment, epithelial cell death is detected. Cremophor EL decreases cell viability and increases cell toxicity more than RH40. Both epithelial viability and monolayer integrity are seriously impaired at 10 to 50 mg/mL concentrations of Cremophor EL at 24-h treatment. Cremophor EL also enhances cell detachment[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

CAS 号

61791-12-6

中文名称

聚氧乙烯蓖麻油EL

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4deg;C, protect from light

溶解性数据
In Vitro:;

Ethanol : 50 mg/mL (Need ultrasonic)

H2O : 25 mg/mL (Need ultrasonic)

参考文献
  • [1]. Kiss L, et al. Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells. J Pharm Sci. 2013 Apr;102(4):1173-81.

Cell Assay
[1]

Cell viability is determined by double fluorescent staining: bis-benzimide labels all cell nuclei, ethidium-homodimer-1 stains only dead cells. For morphological examinations, primary brain endothelial cells with tight barrier properties are used. Cells grown on glass coverslips are treated with Cremophor EL and RH40 for 1 and 24 h. Cremophor EL and RH40 are tested at 0.1 to 50 mg/mL concentrations. Triton X-100 detergent (10 mg/mL) is used in toxicity assays as a reference compound to cause cell death[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

参考文献
  • [1]. Kiss L, et al. Kinetic analysis of the toxicity of pharmaceutical excipients Cremophor EL and RH40 on endothelial and epithelial cells. J Pharm Sci. 2013 Apr;102(4):1173-81.